Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Reduced Proteasomal Activity in Marrow Cells From Myelodysplastic Syndrome (MDS) Patients.

Stela Karabina, Eleni Thanopoulou, Sotirios D Athanasiou, Argiris Symeonidis, Nicholas Zoumbos

Blood (2009) 114 (22): 1776.

https://doi.org/10.1182/blood.V114.22.1776.1776

Published: 2009

Journal Articles

C-JUN-NH2-Terminal Kinase Promotes Apoptosis, Suppresses P-Glycoprotein Mediated Multidrug Resistance but Enhances MRP Mediated Efflux in AML Cells.

Eleni D. Lagadinou, Panos Ziros, Olga Tsopra, Eleni Thanopoulou, Alexandra Kouraklis, Marina Karakantza, Nicholas C. Zoumbos

Blood (2006) 108 (11): 4379.

https://doi.org/10.1182/blood.V108.11.4379.4379

Published: 2006

Journal Articles

Anemia Associated with Chronic Disease in Patients with Chronic Lymphocytic Leukemia Is Not Attributed to Decreased Production or Impaired EPO Signaling of Erythroid Precursors.

Olga Tsopra, Panos Ziros, Eleni Lagadinou, Alexandra Kouraklis, Argiris Symeonidis, Eleni Thanopoulou, Panagiotis Zikos, Nicholas C. Zoumbos

Blood (2006) 108 (11): 4940.

https://doi.org/10.1182/blood.V108.11.4940.4940

Published: 2006

Journal Articles

CD34+ Marrow Cells from MDS Patients Express Homing-Associated Cell Surface Molecules but Impaired In Vitro Migration.

Eleni Thanopoulou, Alexandra Kouraklis-Symeonidis, Argiris Symeonidis, Evangelia Tzouvara, Lorna Pherson, Nicholas Zoumbos

Blood (2005) 106 (11): 3425.

https://doi.org/10.1182/blood.V106.11.3425.3425

Published: 2005

Journal Articles

Neither the Response of Committed Progenitors to Growth Factors nor the Detection of Apoptosis in Bone Marrow Cells Can Predict the Clinical Response to Treatment in Patients with Rars.

Alexandra Kouraklis, Argiris Symeonidis, Eleni Thanopoulou, Panagiota Tsoplou, Anastasia Galani, Nicolas Zoumbos

Blood (2004) 104 (11): 1442.

https://doi.org/10.1182/blood.V104.11.1442.1442

Published: 2004

Journal Articles

Engraftment of NOD/SCID-β2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome

Eleni Thanopoulou, Johanne Cashman, Theodora Kakagianne, Allen Eaves, Nicholas Zoumbos, Connie Eaves

Blood (2004) 103 (11): 4285–4293.

https://doi.org/10.1182/blood-2003-09-3192

Published: 2004

NARROW

Reduced Proteasomal Activity in Marrow Cells From Myelodysplastic Syndrome (MDS) Patients.

C-JUN-NH2-Terminal Kinase Promotes Apoptosis, Suppresses P-Glycoprotein Mediated Multidrug Resistance but Enhances MRP Mediated Efflux in AML Cells.

Anemia Associated with Chronic Disease in Patients with Chronic Lymphocytic Leukemia Is Not Attributed to Decreased Production or Impaired EPO Signaling of Erythroid Precursors.

CD34+ Marrow Cells from MDS Patients Express Homing-Associated Cell Surface Molecules but Impaired In Vitro Migration.

Neither the Response of Committed Progenitors to Growth Factors nor the Detection of Apoptosis in Bone Marrow Cells Can Predict the Clinical Response to Treatment in Patients with Rars.

Engraftment of NOD/SCID-β2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome

Email alerts

ASH Publications

American Society of Hematology

Reduced Proteasomal Activity in Marrow Cells From Myelodysplastic Syndrome (MDS) Patients.

C-JUN-NH2-Terminal Kinase Promotes Apoptosis, Suppresses P-Glycoprotein Mediated Multidrug Resistance but Enhances MRP Mediated Efflux in AML Cells.

Anemia Associated with Chronic Disease in Patients with Chronic Lymphocytic Leukemia Is Not Attributed to Decreased Production or Impaired EPO Signaling of Erythroid Precursors.

CD34+ Marrow Cells from MDS Patients Express Homing-Associated Cell Surface Molecules but Impaired In Vitro Migration.

Neither the Response of Committed Progenitors to Growth Factors nor the Detection of Apoptosis in Bone Marrow Cells Can Predict the Clinical Response to Treatment in Patients with Rars.

Engraftment of NOD/SCID-β2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only